Nuclear Techniques ›› 2020, Vol. 43 ›› Issue (9): 90301-090301.doi: 10.11889/j.0253-3219.2020.hjs.43.090301

• NUCLEAR CHEMISTRY, RADIOCHEMISTRY, RADIOPHARMACEUTICALS AND NUCLEAR MEDICINE • Previous Articles     Next Articles

Guidance on quality control of nuclear medicine in Yangtze River Delta region during regular epidemic prevention and control period of the novel coronavirus pneumonia

Yujing ZHOU1,2,Mengjie DONG3,Shibiao SANG4,Xuegong LIU5(),Xingdang LIU1,2,6()   

  1. 1.Department of Nuclear Medicine, Huashan Hospital, Fudan University,Shanghai 200040,China
    2.Department of Nuclear Medicine, Fudan University Pudong Medical Center, Shanghai 201200, China
    3.Zhejiang Nuclear Medicine Quality Control Center, Hangzhou 310003, China
    4.Jiangsu Nuclear Medicine Quality Control Center, Nanjing 210000, China
    5.Anhui Nuclear Medicine Quality Control Center, Hefei 230001, China
    6.Shanghai Nuclear Medicine Quality Control Center, Shanghai 200040, China
  • Received:2020-06-27 Revised:2020-07-17 Online:2020-09-15 Published:2020-09-09
  • Contact: Xuegong LIU,Xingdang LIU E-mail:lxg1027@sina.com;xingdliu@fudan.edu.cn
  • About author:ZHOU Yujing, female, born in 1991, graduated from Shandong University with a master's degree in 2018, doctoral student, focusing on diagnosis and treatment related to nuclear medicine
  • Supported by:
    National Key Research and Development Plan Digital Diagnosis and Treatment Equipment Research and Development Project: Research and Practice of PET-CT Comprehensive Evaluation System and Training System(2017YFC0113300)

Abstract: Background

The outbreak of corona virus disease (COVID-19) with a high risk of infection occurred in Wuhan city in December 2019, and gradually spread to other places. Current researches have shown that this atypical pneumonia is caused by a novel beta-coronavirus (βCoV), named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The population is generally susceptible to SARS-CoV-2, with an incubation period of 1~14 days, and the transmission routes include droplet transmission, contact transmission, and aerosol transmission. Since the outbreak of pneumonia in China, hospitals throughout the county have concentrated on the treatment of novel coronavirus pneumonia. As a result, routine clinics in hospitals at various levels have been affected. With the control of the epidemic situation in China, medical practice has been gradually restored and our country has entered the stage of regular epidemic prevention and control (EPC). Management of department of nuclear medicine faces new challenges in current regular EPC stage.

Purpose

This study aims to comply with regular epidemic prevention and control of the novel coronavirus pneumonia and provide guidance for the doctors of nuclear medicine in Yangtze River Delta.

Methods

Experts from the Yangtze River Delta region's nuclear medicine quality control center jointly formulated the guiding opinions on quality control of nuclear medicine in Yangtze River Delta region during regular epidemic prevention and control period of the novel coronavirus pneumonia, including in vivo and in vitro detection and ward treatment related to nuclear medicine. [Results and

Conclusions

] Based on its diversity and particularity, the examinations related to nuclear medicine, higher requirements are put forward for nuclear medicine staff for prevention and control of the epidemic. Therefore, a guideline of quality control is needed to ensure the health and safety of the nuclear medicine staff, patients and their accompanying personnel.

Key words: Coronavirus infection, Nuclear medicine, Quality control, Guideline

CLC Number: 

  • R817